Hedeker Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-36,813
| Closed | -$1.35M | – | 92 |
|
|
2023
Q2 | $1.35M | Sell |
36,813
-16,749
| -31% | -$652K | 0.45% | 67 |
|
|
2023
Q1 | $2.19M | Buy |
53,562
+3,685
| +7% | +$159K | 0.78% | 58 |
|
|
2022
Q4 | $2.56M | Buy |
49,877
+11,574
| +30% | +$555K | 0.96% | 49 |
|
|
2022
Q3 | $1.68M | Sell |
38,303
-180
| -0.5% | -$8.75K | 0.65% | 60 |
|
|
2022
Q2 | $2M | Sell |
38,483
-26,589
| -41% | -$1.35M | 0.69% | 46 |
|
|
2022
Q1 | $3.37M | Sell |
65,072
-39,847
| -38% | -$2.07M | 1.02% | 44 |
|
|
2021
Q4 | $6.2M | Sell |
104,919
-1,904
| -2% | -$94.3K | 1.8% | 17 |
|
|
2021
Q3 | $4.59M | Buy |
106,823
+1,012
| +1% | +$44.8K | 1.42% | 25 |
|
|
2021
Q2 | $4.14M | Buy |
105,811
+15,406
| +17% | +$599K | 1.29% | 31 |
|
|
2021
Q1 | $3.27M | Buy |
90,405
+1,864
| +2% | +$66.2K | 1.15% | 35 |
|
|
2020
Q4 | $3.26M | Buy |
88,541
+16,186
| +22% | +$594K | 1.14% | 35 |
|
|
2020
Q3 | $2.52M | Sell |
72,355
-19,278
| -21% | -$676K | 1.19% | 40 |
|
|
2020
Q2 | $2.84M | Sell |
91,633
-18,888
| -17% | -$642K | 1.47% | 33 |
|
|
2020
Q1 | $3.42M | Buy |
110,521
+1,999
| +2% | +$68.1K | 2.16% | 17 |
|
|
2019
Q4 | $4.03M | Buy |
108,522
+19,450
| +22% | +$693K | 2.16% | 17 |
|
|
2019
Q3 | $3.04M | Buy |
89,072
+2,195
| +3% | +$79.8K | 1.83% | 26 |
|
|
2019
Q2 | $3.57M | Buy |
86,877
+13,253
| +18% | +$526K | 2.26% | 16 |
|
|
2019
Q1 | $3.03M | Buy |
73,624
+951
| +1% | +$38.1K | 2.29% | 12 |
|
|
2018
Q4 | $3.01M | Sell |
72,673
-639
| -0.9% | -$26.5K | 2.41% | 13 |
|
|
2018
Q3 | $3.06M | Sell |
73,312
-1,394
| -2% | -$53.7K | 2.15% | 13 |
|
|
2018
Q2 | $2.57M | Sell |
74,706
-2,966
| -4% | -$101K | 1.97% | 15 |
|
|
2018
Q1 | $2.62M | Buy |
77,672
+920
| +1% | +$31.6K | 2.02% | 17 |
|
|
2017
Q4 | $2.64M | Buy |
76,752
+4,712
| +7% | +$161K | 2.05% | 14 |
|
|
2017
Q3 | $2.44M | Buy |
72,040
+19,685
| +38% | +$633K | 2.15% | 14 |
|
|
2017
Q2 | $1.67M | Buy |
52,355
+274
| +0.5% | +$8.64K | 1.6% | 25 |
|
|
2017
Q1 | $1.69M | Sell |
52,081
-6,364
| -11% | -$201K | 1.6% | 21 |
|
|
2016
Q4 | $1.8M | Buy |
58,445
+55,927
| +2,221% | +$1.71M | 1.48% | 21 |
|
|
2016
Q3 | $70.6K | Sell |
2,518
-43,327
| -95% | -$1.45M | 3.65% | 4 |
|
|
2016
Q2 | $1.53M | Buy |
+45,845
| New | +$1.46M | 1.34% | 25 |
|
|
2016
Q1 | – | Sell |
-1,014
| Closed | -$31K | – | 141 |
|
|
2015
Q4 | $31K | Buy |
+1,014
| New | +$31.9K | 0.03% | 101 |
|
|
2015
Q3 | – | Sell |
-1,014
| Closed | -$32K | – | 143 |
|
|
2015
Q2 | $32K | Buy |
+1,014
| New | +$33K | 0.03% | 115 |
|
|
2015
Q1 | – | Sell |
-1,014
| Closed | -$30K | – | 138 |
|
|
2014
Q4 | $30K | Buy |
+1,014
| New | +$29.1K | 0.02% | 107 |
|
Other funds holding PFE
Hedeker Wealth's PFE Position: Q3 2023 in Review
Hedeker Wealth sold out of Pfizer (PFE) in Q3 2023, closing a stake of 36,813 shares — an estimated $1.35M sold.
Hedeker Wealth first reported a position in PFE in Q4 2014 and held it in 32 quarters. The position peaked at $6.2M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Hedeker Wealth reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Hedeker Wealth sold 36,813 Pfizer shares in Q3 2023, an estimated $1.35M.
- Hedeker Wealth first reported a position in Pfizer in Q4 2014 and held it in 32 quarters.
- Hedeker Wealth's Pfizer position peaked at $6.2M in Q4 2021.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Hedeker Wealth's 13F filing for Q3 2023, filed 7 Nov 2023.